Genomic profiling of sinonasal squamous cell carcinoma

Head and Neck

Volumn 33, Issue 2, 2011, Pages 145-153

  López, Fernando ^a   Llorente, José L ^a   García Inclán, Cristina ^a   Alonso Guervós, Marta ^a   Cuesta Albalad, Mari Paz ^a   Fresno, Manuel Florentino ^b   Álvarez Marcos, César ^a   Suárez, Carlos ^a   Hermsen, Mario A ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

ethmoid sinus; maxillary sinus; microarray CGH; MLPA; squamous cell carcinoma

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; ETHMOID SINUS; FEMALE; FOLLOW UP; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MALE; MAXILLARY SINUS; MICROARRAY ANALYSIS; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NOSE CARCINOMA; PARANASAL SINUS CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSIS, DIFFERENTIAL; DNA COPY NUMBER VARIATIONS; FEMALE; FOLLOW-UP STUDIES; GENE AMPLIFICATION; GENES, P53; GENOME; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MAXILLARY SINUS NEOPLASMS; MICROARRAY ANALYSIS; MIDDLE AGED; MUTATION; NOSE NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78751515740     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21417     Document Type: Article

References (37)

1. Shah JP, Patel SG,. Cavidad nasal y senos paranasales. In:, Shah J, editor. Cirugía y oncología de cabeza y cuello. Madrid: Elsevier; 2004. pp 57-93.
2. Gras Cabrerizo JR, Sarandeses García A, Montserrat i Gili JR, OrÃs Dotà C,. Revisión de los carcinomas de senos paranasales. Acta Otorrinolaringol Esp 2007; 58: 266-275.
3. Suárez Nieto C, Llorente Pendás JL,. Tumores malignos de fosas nasales y senos paranasales. In:, Suárez Nieto C, editor. Oncología de cabeza y cuello. Barcelona: Ars Médica; 2002. pp 75-90.
4. Dulguerov P, Jacobsen M, Allal A, Lehman W, Calcaterra T,. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and systematic review. Cancer 2001; 92: 3012-3029.
5. Nuñez F, Suárez C, Álvarez I, Losa JL, Barthe P, Fresno MF,. Sino-nasal adenocarcinoma: epidemiological and clinicopathological study of 34 cases. J Otolaryngol 1993; 22: 86-90.
6. Dulguerov P, Allal AS,. Nasal and paranasal sinus carcinoma: how can we continue to make progress? Curr Opin Otolaryngol Head Neck Surg 2006; 14: 67-72.
7. Konno A, Ishikawa K, Terada N, Numata T, Nagata H, Okamoto Y,. Analysis of long-term results of our combination therapy for squamous cell cancer of the maxillary sinus. Acta Otolaryngol (Stockh) 1998; 118 (Suppl 537): 57-66. (Pubitemid 28545378)
8. Nishino H, Miyata M, Morita M, Ishikawa K, Kanazawa T, Ichimura K,. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer 2000; 89: 1925-1932.
9. Nibu K, Sugasawa M, Asai M, et al. Results of multimodality therapy for squamous cell carcinoma of maxillary sinus. Cancer 2002; 94: 1476-1482.
10. Mannetje A, Kogevinas M, Luce D, et al. Sinonasal cancer, occupation, and tobacco smoking in European women and men. Am J Ind Med 1999; 36: 101-107.
11. Götte K, Hörmann K,. Sinonasal malignancy: what's new? Review. ORL J Otorhinolaryngol Relat Spec 2004; 66: 85-97.
12. Luce D, Leclerc A, Begin D, et al. Sinonasal cancer and occupational exposures: a pooled analysis of 12 case-control studies. Cancer Causes Control 2002; 13: 147-157.
13. Zheng W, McLaughlin JK, Chow WH, Chien HT, Blot WJ,. Risk factors for cancers of the nasal cavity and paranasal sinuses among white men in the United States. Am J Epidemiol 1993; 138: 965-972.
14. Holt GR,. Sinonasal neoplasm and inhaled air toxics. Otolaryngol Head Neck Surg 1994; 11: 12-14.
15. Bandoh N, Hayashi T, Takahara M, et al. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis. Cancer Lett 2004; 208: 215-225.
16. Bandoh N, Hayashi T, Kishibe K, et al. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 2002; 94: 1968-1980.
17. Holmila R, Cyr D, Luce D, et al. COX-2 and p53 in human sinonasal cancer: COX-2 expression is associated with adenocarcinoma histology and wood-dust exposure. Int J Cancer 2008; 122: 2154-2159.
18. Bornholdt J, Hansen J, Steiniche T, et al. K-ras mutations in sinonasal cancers in relation to wood dust exposure. BMC Cancer 2008; 8: 53 (abstract).
19. Götte K, Riedel F, Schäfer C, Coy J, Hörmann K,. Cylindrical cell carcinomas of the paranasal sinuses do not show p53 alterations but loss of heterozygosity at 3p and 17p. Int J Cancer 2000; 85: 740-742.
20. Gil Z, Orr-Urtreger A, Voskoboinik N, et al. Cytogenetic analysis of sinonasal carcinomas. Otolaryngol Head Neck Surg 2006; 134: 654-660.
21. Jin Y, Mertens F, Arheden K, et al. Karyotypic features of malignant tumors of the nasal cavity and paranasal sinuses. Int J Cancer 1995; 60: 637-641.
22. Sobin LH, Wittekind C,. UICC TNM classification of malignant tumors, 6th ed. New York: Wiley-Liss; 2002.
23. Guervós MA, Marcos CA, Hermsen M, Nuño AS, Suárez C, Llorente JL,. Deletions of N33, STK11 and TP53 are involved in the development of lymph node metastasis in larynx and pharynx carcinomas. Cell Oncol 2007; 29: 327-334.
24. van den IJssel P, Tijssen M, Chin S-F, et al. Human and mouse oligonucleotide-based array CGH. Nucleic Acids Res 2005; 33: e192-e192(1).
25. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-2492.
26. Hermsen M, Alonso Guervós M, Meijer G, et al. Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cell Oncol 2005; 27: 191-198.
27. Snijders AM, Schmidt BL, Fridlyand J, et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene 2005; 24: 4232-4242.
28. Järvinen AK, Autio R, Kilpinen S, et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 2008; 47: 500-509.
29. Batsakis JG, Suárez P,. Schneiderian papillomas and carcinomas: a review. Adv Anat Pathol 2001; 8: 53-64.
30. Caruana SM, Zwiebel N, Cocker R, McCormick SA, Eberle RC, Lazarus P,. p53 alteration and human papilloma virus infection in paranasal sinus cancer. Cancer 1997; 79: 1320-1328.
31. Califano J, Koch W, Sidransky D, Westra WH,. Inverted sinonasal papilloma: a molecular genetic appraisal of its putative status as a precursor to squamous cell carcinoma. Am J Pathol 2000; 156: 333-337.
32. Singh B, Wreesmann VB, Pfister D, et al. Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet 2002; 3: 22 (abstract).
33. Bentires-Alj M, Neel BG,. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Res 2007; 67: 2420-2424.
34. Weiss MM, Kuipers EJ, Postma C, et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003; 22: 1872-1879.
35. Akao J, Matsuyama H, Yamamoto Y, Sasaki K, Naito K,. Chromosome 20q13.2 gain may predict intravesical recurrence after nephroureterectomy in upper urinary tract urothelial tumors. Clin Cancer Res 2006; 12: 7004-7008.
36. Carvalho B, Postma C, Mongera S, et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 2009; 58: 79-89.
37. Astsaturov I, Cohen RB, Harari PM,. EGFR-targeting monoclonal antibodies in head and neck cancer. Curr Cancer Drug Targets 2006; 6: 691-710.